Atom Investors LP raised its stake in shares of The Ensign Group, Inc. (NASDAQ:ENSG – Free Report) by 50.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 32,943 shares of the company’s stock after purchasing an additional 11,055 shares during the period. Atom Investors LP owned 0.06% of The Ensign Group worth $5,739,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Parkside Financial Bank & Trust grew its holdings in The Ensign Group by 2.9% during the fourth quarter. Parkside Financial Bank & Trust now owns 2,000 shares of the company’s stock valued at $348,000 after purchasing an additional 57 shares during the last quarter. Csenge Advisory Group grew its holdings in The Ensign Group by 3.7% during the fourth quarter. Csenge Advisory Group now owns 1,642 shares of the company’s stock valued at $286,000 after purchasing an additional 58 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in The Ensign Group by 55.0% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company’s stock valued at $30,000 after purchasing an additional 61 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its holdings in The Ensign Group by 2.9% during the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 2,189 shares of the company’s stock valued at $381,000 after purchasing an additional 62 shares during the last quarter. Finally, CBIZ Investment Advisory Services LLC increased its stake in shares of The Ensign Group by 18.1% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 412 shares of the company’s stock worth $72,000 after purchasing an additional 63 shares during the period. Institutional investors and hedge funds own 96.12% of the company’s stock.
The Ensign Group Trading Up 4.1%
The Ensign Group stock opened at $156.93 on Wednesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.56. The business’s 50-day simple moving average is $178.21 and its 200-day simple moving average is $186.27. The firm has a market capitalization of $9.17 billion, a PE ratio of 25.56, a PEG ratio of 1.47 and a beta of 0.68. The Ensign Group, Inc. has a 52 week low of $134.79 and a 52 week high of $218.00.
The Ensign Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Thursday, April 30th. Investors of record on Tuesday, March 31st were paid a dividend of $0.065 per share. This represents a $0.26 annualized dividend and a yield of 0.2%. The ex-dividend date was Tuesday, March 31st. The Ensign Group’s payout ratio is currently 4.23%.
Trending Headlines about The Ensign Group
Here are the key news stories impacting The Ensign Group this week:
- Positive Sentiment: The company expanded its stock repurchase authorization by $60 million to a total of $100 million, which can signal confidence from management and provide support for the share price. The Ensign Group, Inc. Announces Increased Stock Repurchase Authorization
- Positive Sentiment: Analyst-style commentary highlighted Ensign as a strong growth stock, reinforcing the view that the company still has underlying earnings and operating momentum. Here’s Why Ensign Group (ENSG) is a Strong Growth Stock
- Neutral Sentiment: Zacks also framed the expanded buyback as potentially positive for investors, but it is largely a read on capital allocation rather than a new operating update. Is ENSG’s Expanded $100M Buyback Program a Positive for Investors?
- Negative Sentiment: Multiple law firms launched investigations into possible securities law violations after critical reports alleged patient-care issues, quality-measure gaming, and improper billing, which is a major overhang for the stock. ENSG ALERT: Investigation Launched into The Ensign Group, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
- Negative Sentiment: Additional investor alerts from Rosen, Pomerantz, Holzer & Holzer, and Hagens Berman point to escalating legal scrutiny and risk of further downside if the allegations gain traction. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Ensign Group, Inc. – ENSG
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on ENSG shares. Wall Street Zen upgraded The Ensign Group from a “hold” rating to a “buy” rating in a research note on Sunday. Weiss Ratings reiterated a “buy (b)” rating on shares of The Ensign Group in a research note on Tuesday, April 21st. Zacks Research lowered The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Finally, Royal Bank Of Canada reiterated an “outperform” rating on shares of The Ensign Group in a research note on Tuesday, June 9th. Four analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $216.75.
Check Out Our Latest Stock Report on ENSG
Insider Activity
In related news, Director Barry M. Smith sold 700 shares of the business’s stock in a transaction dated Thursday, April 2nd. The stock was sold at an average price of $196.65, for a total transaction of $137,655.00. Following the transaction, the director directly owned 22,152 shares in the company, valued at $4,356,190.80. The trade was a 3.06% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the business’s stock in a transaction dated Monday, April 20th. The shares were sold at an average price of $199.97, for a total value of $78,388.24. Following the transaction, the director owned 9,295 shares in the company, valued at $1,858,721.15. This represents a 4.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,592 shares of company stock worth $478,246 over the last 90 days. Corporate insiders own 4.00% of the company’s stock.
The Ensign Group Profile
The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.
Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.
See Also
- Five stocks we like better than The Ensign Group
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding ENSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Ensign Group, Inc. (NASDAQ:ENSG – Free Report).
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.
